Overexpression of multiple epidermal growth factor like domains 11 rescues anoikis survival through tumor cells-platelet interaction in triple negative breast Cancer cells
Open Access
- 7 April 2022
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 299, 120541
Abstract
No abstract availableKeywords
Funding Information
- Taipei Veterans General Hospital
- Taiwan Ministry of Health and Welfare
This publication has 29 references indexed in Scilit:
- A novel mechanism of sustained platelet αIIbβ3 activation via PEAR1Blood, 2012
- Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer modelActa Pharmacologica Sinica, 2012
- Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune CellsCancer Research, 2012
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJournal of Clinical Investigation, 2011
- Triple‐negative breast cancer: Present challenges and new perspectivesMolecular Oncology, 2010
- Jedi—a novel transmembrane protein expressed in early hematopoietic cellsJournal of Cellular Biochemistry, 2007
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004
- Targeting mTOR signaling for cancer therapyCurrent Opinion in Pharmacology, 2003
- Calcein-Acetyoxymethyl Cytotoxicity Assay: Standardization of a Method Allowing Additional Analyses on Recovered Effector Cells and SupernatantsClinical and Diagnostic Laboratory Immunology, 2001
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976